PHARMACY

Study shows Roche dyslipidemia treatment well-tolerated

BY Drew Buono

Basel, Switzerland Data from a phase II trial shows that Roche’s investigational cholesteryl ester transfer protein inhibitor R1658 is well tolerated and does not raise blood pressure. The company presented these findings at the 57th Annual Scientific Session of the American College of Cardiology.

Roche is developing R1658 as a treatment for dyslipidemia, a condition that results in abnormal lipid and lipoprotein levels in the bloodstream and an increased risk of cardiovascular disease.

Results showed that, after four weeks, R1658 taken alone or in combination with Bristol-Myers Squibb’s Pravachol, Pfizer’s Lipitor or Merck’s Zocor was generally well-tolerated and did not cause an increase in cardiovascular adverse events or changes in blood pressure compared with a placebo. Side effects included gastrointestinal disorders, headache and dizziness.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Teva pays $7.5 million to settle IVAX lawsuit with Depomed

BY Drew Buono

MENLO PARK, Calif. Depomed will receive a one-time payment of $7.5 million from Teva Pharmaceuticals generic unit IVAX in relation to a settlement of a patent lawsuit, according to published reports.

Depomed had sued IVAX in January 2006 claiming patent infringement by IVAX’s Glucophage XR, a diabetes medication.

Under the terms of the settlement, Depomed will also get up to $2.5 million in royalties, for granting Teva a non-exclusive license allowing it to continue marketing the generic version of Glucophage XR.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

SynaMed launches free online PHR

BY Drew Buono

NEW YORK SynaMed has launched its free online personal health record, which will be available to all patients.

“SynaMed simplifies record keeping so that patients do not have to rely on memory. A personal health record can also provide lifesaving medical information when a patient is not able to speak for themselves,” according to Holly DeMuro, SynaMed’s director of operations. SynaMed’s personal health record system uses a Web browser-based application service provider model, which allows patients access anytime, from anywhere with Internet connection.

Patients using SynaMed’s personal health record will be able to record all of their medical history, doctor’s visits, check insurance coverage for medications, and receive health maintenance reminders about wellness issues and checkups. “Going forward, SynaMed will be expanding the Personal Health Record to include overall health information such as mood, weight, diet, and exercise trackers. This feature will be the first complete online wellness center,” DeMuro said.

In addition to a state of the art PHR, SynaMed offers a free fully integrated electronic medical record and practice management system to medical practitioners.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?